Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2026 Update
GMO Capital's Q1 2026 portfolio update reveals significant shifts towards large-cap technology and healthcare stocks. The firm has added positions in Microsoft, Broadcom, and Salesforce while reducing its holdings in Lam Research and Wells Fargo. This strategic reallocation reflects a focus on quality investments amidst changing market conditions.
- ▪GMO's portfolio is valued at $39 billion according to their latest 13F filing.
- ▪The firm has increased its investments in Microsoft, Broadcom, and Salesforce.
- ▪GMO has trimmed its positions in Lam Research and Wells Fargo.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":{"id":"DoxFkP"},"item":"https://seekingalpha.com/latest-articles"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4911215-jeremy-grantham-gmo-capital-portfolio-q1-2026-update"},"author":{"@type":"Person","name":"John Vincent","url":"https://seekingalpha.com/author/john-vincent"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
